CGON

CG Oncology Inc. Common stock (CGON)

Stock · NASDAQ · Health Care

$74.34as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Support level
$69.81
Industry
Biotechnology: Biological Products (No Diagnostic Substances)

CG Oncology Inc. Common stock Competitors

Chosen by industry and closest market cap.

  • CGON
    CG Oncology Inc. Common stock
    $74.34
    ▼ 5.91%
    Market cap $6.10BP/E
  • CRSP
    CRISPR Therapeutics AG Common Shares
    $57.69
    ▼ 2.84%
    Market cap $4.78BP/E
    $44.12$78.48
  • KYMR
    Kymera Therapeutics Inc. Common Stock
    $118.08
    ▼ 1.79%
    Market cap $8.25BP/E
    $39.84$130.05
  • ADPT
    Adaptive Biotechnologies Corporation Common Stock
    $25.19
    ▼ 4.73%
    Market cap $3.70BP/E
    $12$26.87
  • RLAY
    Relay Therapeutics Inc. Common Stock
    $18.78
    ▼ 3.30%
    Market cap $3.60BP/E
    $3.5$21.27
  • QGEN
    Qiagen N.V. Common Shares
    $43.12
    ▼ 1.43%
    Market cap $8.72BP/E 22.14
    $32.53$57.82
  • BEAM
    Beam Therapeutics Inc. Common Stock
    $29.31
    ▼ 3.84%
    Market cap $2.67BP/E
    $16.02$38.26

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
88.14M
Total value held
$5.20B
Institutional holders
232
Top holders this quarter
  • Unknown6.98M
  • Unknown6.72M
  • Unknown6.37M
  • Unknown5.37M
  • Unknown5.06M
  • Unknown3.76M
  • Unknown3.67M
  • Unknown3.65M
  • Unknown3.03M
  • Unknown2.76M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.